23.4 C
New York
Monday, June 15, 2026

Tag: executive leadership

newssourceFORcompanyinformationcontent1marketreleases

Refresco Appoints Steve Presley as CEO

Press Release

Refresco Appoints Steve Presley as CEO

Ipsen announces changes to its Executive Committee

PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its Executive Committee:

Northwest University Names New President

KIRKLAND, Wash., July 22, 2025 /PRNewswire/ -- Today, Northwest University (NU) announces the appointment of Jeremy Johnson, Ed.D, as President, effective August 18, 2025,...

Amplify Energy Announces Strategic Update and CEO Transition

HOUSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) today announced an update on strategic initiatives and changes to the executive leadership team.

Llusern Scientific Announces Key Appointments to Strengthen its Executive Team

CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide 
CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide

A New Mining Model Built for Speed, Scale and Profit

NetworkNewsWire Editorial Coverage NEW YORK, July 17, 2025 /PRNewswire/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...

A New Mining Model Built for Speed, Scale and Profit

NetworkNewsWire Editorial Coverage NEW YORK, July 17, 2025 /CNW/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...

A New Mining Model Built for Speed, Scale and Profit

NetworkNewsWire Editorial Coverage NEW YORK, July 17, 2025 /PRNewswire/ -- For years, the mining industry has revolved around high-risk, capital-intensive exploration, where the odds of...

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Directors. He takes over from Ruth McKernan, who retains her role on the Board as a Director and Interim Chief Executive Officer (CEO).

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 15, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

TC Energy to issue second quarter 2025 results on July 31

CALGARY, Alberta, July 10, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will hold a teleconference and webcast on Thursday, July 31, 2025, to discuss its second quarter financial results.

VIVO Agency Names Jennifer Mugnaini as EVP of Client Services

Strategic hire reinforces VIVO's commitment to client leadership and growth NEWTOWN, Pa., July 10, 2025 /PRNewswire/ -- VIVO Agency, a strategic marketing partner for MedTech...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsExecutive leadership

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers